ATG5 and lysosomal storage disease: Lysosomal lipid deposition was observed in control cells, whereas inhibition of autophagy following treatment with 3MA and siRNA targeting ATG5, or inhibition of ROS with NAC, both resulted in a profound increase in lysosomal lipid deposition, with larger lysosome marking lysosomal storage disorders.